CMO Yu Jeffrey Invests $250K in OneMedNet at $5.54 Per Share
ONMD is trading near its 52-week low of $3.61 (11% above the low) on light trading volume (0.3× avg).
Summary
OneMedNet's Chief Medical Officer Yu Jeffrey purchased $249,998 of company stock at $5.54 per share, adding to a 90-day insider accumulation trend of nearly $1.1 million.
Key Events · Ownership and Investor Activity · ONMD
-
CMO Buys $250K in Open Market
Chief Medical Officer Yu Jeffrey acquired 45,126 shares for $249,998.04 at $5.54 per share on October 9, 2026, via a subscription agreement.
-
Priced at 10-Day VWAP
The purchase price was set at the volume-weighted average price over the 10 trading days prior to the purchase date, not the spot price on the transaction date.
-
Insider Accumulation Trend
This purchase extends a 90-day pattern of insider buying totaling approximately $1.09 million across four insiders, with net open-market accumulation of $986,947.
-
Post-Split Positioning
The purchase follows the company's 1-for-10 reverse stock split effective September 29, 2026, which reduced the share count from approximately 60.1 million to about 6 million shares.
Analysis · ONMD · Industrial Applications And Services
Chief Medical Officer Yu Jeffrey put $249,998 into OneMedNet common stock on October 9, 2026, buying 45,126 shares at $5.54 each—the 10-day VWAP before the purchase. This is a direct open-market purchase, not an option exercise or grant, and it comes just weeks after the company completed a 1-for-10 reverse stock split on September 29 to avoid Nasdaq delisting. The purchase represents roughly 1% of the company's market cap and follows a broader pattern of insider accumulation: four insiders have bought approximately $1.09 million in open-market shares over the past 90 days. The transaction was executed via a subscription agreement, indicating a negotiated capital infusion rather than a routine market order. Against a backdrop of dwindling cash ($0.4 million as of the last 10-Q) and a $25 million equity line with Yorkville, this insider commitment is a meaningful vote of confidence in the company's turnaround, though it also highlights the company's reliance on insider and related-party funding.
How filings like this one have moved
In the 30 days to Oct 14, 2026, 36.5% of the 995 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ONMD was trading at $4.02 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $24.2M. The 52-week trading range was $3.61 to $34.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.